222

ST PHARM

No trades
See on Supercharts
Market capitalization
‪1.66 T‬KRW
‪19.58 B‬KRW
‪284.99 B‬KRW
‪9.94 M‬
Beta (1Y)
1.06

About ST PHARM

CEO
Gyeong-Jin Kim
Headquarters
Siheung
Employees (FY)
669
Founded
1983
ISIN
KR7237690003
FIGI
BBG00CX93J57
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug CMO business offers services such as process optimization, documentation support, and validation. The Generic APIs business produces APIs for anti-cancer, tubeculosis, coagulant, and fungal, asthma, diabetes mellitus, hepatitis B, and Epilepsy treating drugs. The Fine Chemical business offers pharmaceutical intermediates. The Bio business develops and produces ribonucleic acid therapeutics and phosphoamidite monomers. The company was founded in 1983 and is headquartered in Siheung, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 237690 is 87100 KRW — it has decreased by 1.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ST PHARM stocks are traded under the ticker 237690.
237690 stock is 2.42% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is ST PHARM there?
ST PHARM revenue for the last quarter amounts to ‪55.90 B‬ KRW despite the estimated figure of ‪71.33 B‬ KRW. In the next quarter revenue is expected to reach ‪114.15 B‬ KRW.
Yes, you can track ST PHARM financials in yearly and quarterly reports right on TradingView.
237690 stock has risen by 7.66% compared to the previous week, the month change is a 4.60% fall, over the last year ST PHARM has showed a 11.95% increase.
237690 net income for the last quarter is ‪10.53 B‬ KRW, while the quarter before that showed ‪3.93 B‬ KRW of net income which accounts for 167.91% change. Track more ST PHARM financial stats to get the full picture.
Today ST PHARM has the market capitalization of ‪1.66 T‬, it has increased by 2.93% over the last week.
Yes, 237690 dividends are paid annually. The last dividend per share was 500.00 KRW. As of today, Dividend Yield (TTM)% is 0.57%. Tracking ST PHARM dividends might help you take more informed decisions.
ST PHARM dividend yield was 0.74% in 2023, and payout ratio reached 48.03%. The year before the numbers were 0.57% and 52.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 237690 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ST PHARM stock right from TradingView charts — choose your broker and connect to your account.
237690 reached its all-time high on Dec 29, 2021 with the price of 150800 KRW, and its all-time low was 12300 KRW and was reached on Aug 6, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 669.00 employees. See our rating of the largest employees — is ST PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ST PHARM technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ST PHARM stock shows the strong buy signal. See more of ST PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ST PHARM future price: according to them, 237690 price has a max estimate of 140000.00 KRW and a min estimate of 96000.00 KRW. Read a more detailed ST PHARM forecast: see what analysts think of ST PHARM and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ST PHARM EBITDA is ‪56.49 B‬ KRW, and current EBITDA margin is 18.97%. See more stats in ST PHARM financial statements.